(1) The renal changes in acute tubular necrosis in cases have been traced through the natural history of the syndrome, by both microdissection and histological preparations.
OLIVER, J., MACDOWELL, M., and TRACY, A. (1951) J. clin. Invest., 30, 1307. WARDENER, H. E. DE (1955) Lancet, i, 580. [February 26, 19571 DISCUSSION ON THE PHARMACOLOGICAL AND MEDICAL ASPECTS OF SMOKING Professor J. H. Burn (Department of Pharmacology, Oxford University): The Pharmacology of Smoking Amounts of nicotine received in smoking.-The observation that nicotine stimulates sympathetic ganglia is now an old one, and most people remember that the stimulant action passes over to a paralysing action when nicotine is applied. In the amounts which normally reach man, however, it is a ganglionic stimulant. I would like to begin my remarks with a consideration of this very point. How much nicotine does a man smoking a cigarette take in? There have been some surprising estimates, which seem to me too high. Thus Haag and Larson (1944) have concluded that cigarette smokers who inhale retain about 3 mg. nicotine from each cigarette, while those who do not inhale retain 035 mg. Now observations made in my own department by Ling and Wynn Parry (1949) suggested that the amounts were much smaller. They set up a long glass U-tube each arm of which was 50 cm. long and of internal diameter 1 cm. The U-tube was immersed in running cold water. To one side of the U-tube a holder was attached in which a cigarette could be fixed, and the other side was attached to a 50 ml. flask which was in turn attached to a filter pump which applied weak suction. A T-piece near the pump could be opened or closed so as to allow suction to draw air through the cigarette at intervals similar to those used by a smoker in smoking a cigarette. Usually 5 cigarettes were "smoked" in succession, and the nicotine condensed in the U-tube and in the flask was then collected and estimated. The deposit was dissolved in weak acid, made alkaline and extracted with ether. The ether extract was allowed to dry and the nicotine was taken up in 1 % tartaric acid. It was then estimated on the blood pressure of a spinal cat. Results were obtained by Ling in 1935 and by Wynn Parry in 1948. They showed that the amount of nicotine entering the mouth during the smoking of one cigarette, which contains 1 gram tobacco, is between 0-6 mg. and 1I0 mg. The cigarettes used were the brands commonly smoked in Britain, including Players, Gold Flake and State Express.
This result gains confirmation from observations published by Burn et al. (1945) on the antidiuretic action of nicotine. Thus one subject who drank 1 litre of warm water and measured its rate of excretion by emptying his bladder at 15 min. 'intervals, smoked one cigarette, inhaling deeply, 45 min. after drinking the water. This caused inhibition of the diuresis for over one hour, the interval between the maximum rate of excretion before and after smoking being 105 min. On another occasion he repeated the experiment, but instead of smoking a cigarette, he received an injection of 1 mg. nicotine acid tartrate, corresponding to 0 33 mg. nicotine calculated as base. This produced a longer inhibition of diuresis, the interval between the maximum rate of excretion before and after receiving the injection being 150 min. This, and a similar result in a second subject, suggested that the amount of nicotine reaching the blood when a subject inhales deeply is about 0 3 mg. per cigarette, and probably only one-third of the amount entering the mouth. Thus the figures given for the amounts of nicotine in the smoke of cigarettes by Haag and Larson (1944) and by Wolman (1953) do not apply to cigarettes obtained in Britain. Our lower results may be due to the use of the biological method for estimating nicotine, which ignores related substances which are without physiological action.
Heart-rate and bloodpressure.-That smoking raises the heart-rate and the blood pressure is generally agreed. The rise in heart-rate is to be expected from the stimulation of the stellate ganglia by the nicotine. This would lead to a discharge of impulses along the cardio-accelerator nerves. The rise in blood pressure is also to be expected from the stimulation of the sympathetic ganglia, and, like the rise in heart-rate it may also be due in part to a release of adrenaline and noradrenaline from the adrenal medulla. In normal subjects the rise of blood pressure was found by Roth et al. (1944) to be about 10 to 20 mm., but it was found to be greater in patients with hypertension (Roth, 1954) . In 16 patients whose average blood pressure was 170/117, the average increase caused was 38 mm. systolic and 23 mm. diastolic; 2 cigarettes were smoked in both series.
Peripheral vasoconstriction.-The rise of blood pressure is due, in the main, to vasoconstriction and the vasoconstriction is prominent in the vessels of the skin. Lampson (1935) used a plethysmographic method of measuring the rate of blood flow through the hand, and observed a striking fall in the blood flow when the subject smoked and inhaled a cigarette. The hand was in water at 320 C., and the flow per 100 ml. of hand fell from 19 to 4 ml. per min.
Other observers have recorded changes in skin temperature. Among these have been Barker (1931) , Wright (1933) , Wright and Moffatt (1934) , Maddock et al. (1936) and Roth (1951) . An example of the observations made showed a fall in the surface temperature at the finger tips from 32.50 C. to 25.80 C., the temperature returning to 32.40 C. about 35 min. after the end of smoking.
The explanation of these effects which would naturally be put forward is that the nicotine stimulated the ganglia of the sympathetic chain and so caused the vasoconstriction. It is, however, not certain that the action of the nicotine is only or mainly on the sympathetic chain. In the first place, observations on the perfused vessels of an isolated organ indicate that nicotine has a peripheral constrictor action in addition to its ordinary ganglionic action. This effect was first demonstrated with small doses (5 ,ug.) of nicotine by Haimovici and Pick (1946) in the perfused vessels of the frog. My colleague Kottegoda (1953a) observed a similar effect in the perfused rabbit ear and saw that it was abolished by hexamethonium. This seemed to indicate that nicotine was not acting directly on the vessels, but on some ganglion-like structure, though none was known in the tissues of the ear. Kottegoda also showed that the effect of nicotine was reversed when the vessels were perfused with a solution containing priscol. Now, in the presence of priscol, the constrictor action of adrenaline is reversed to a dilator action, and so it appeared that the constriction caused by nicotine might be due to the release of adrenaline, because the constrictor effect of nicotine was reversed in the presence of priscol. Finally, Ginzel and Kottegoda (1953) made observations on the isolated ears of rabbits in which the sympathetic fibres had degenerated. They removed the superior cervical ganglion and the stellate ganglion on one side, and three weeks later they tested such denervated ears. The action of nicotine was unaltered. In small amounts, e.g. 5 pg., it caused a vasoconstriction which was blocked by hexamethonium, and which was reversed to a vasodilator action in the presence of priscol.
The mechanism of the effect of nicotine is obscure. The effect is clearly independent of the postganglionic sympathetic fibres. Perhaps there is chromaffin tissue surrounding the small vessels of the ear; this tissue, which is present in various parts of the body, contains noradrenaline with a small amount of adrenaline. The action of nicotine may be to release these amines.
These observations may very well have an importance for human skin, particularly in diseases such as thrombo-angiitis obliterans and Raynaud's disease. It appears to be established that smoking may bring on the ulcers and the gangrene which is characteristic of thrombo-angiitis obliterans, and that the condition heals when smoking stops. McDevitt and Wright (1955) quote several cases where the disease was sufficiently severe that an amputation of a limb was required, and where a connexion with smoking was established by a recurrence of attacks when smoking was resumed. One was of a middle-aged physician who had thrombo-angiitis for five years. He had three severe attacks, each' associated with the resumption of smoking.
Another was a patient in the New York Hospital who first had active thrombo-angiitis in 1940. In 1941 he stopped smoking and his symptoms were arrested until 1949 when he started to smoke again. Within three months gangrene of three toes developed. Once more after abstinence from smoking and with other therapy the disease became quiescent. In the spring of 1954 he started to smoke cigarettes with a filter tip and this again made the disease active.
Evidence that in this disease the effect of nicotine is peripheral and independent of sympathetic innervation has been obtained by various observers (Silbert, 1935) . Smoking aggravates the thrombo-angiitic process in limbs in which the sympathetic fibres have degenerated as a result of sympathectomy. The vasospasm of Raynaud's disease is also brought on in some patients as a result of smoking one or two cigarettes.
The coronary circulation.-Perhaps the most serious suspicion regarding nicotine concerns its effect on the coronary circulation. The direct action of nicotine on the vessels is to dilate them, but it has been shown beyond reasonable doubt that nicotine stimulates the supra-optic nucleus and causes a discharge of vasopressin from the posterior lobe of the pituitary gland. This discharge has been demonstrated by its antidiuretic action (Burn et al., 1945) . Now vasopressin causes constriction of the coronary vessels, and the question at issue is whether the amounts of vasopressin discharged during smoking are sufficient to reduce coronary flow. It has been shown that the coronary flow in the dog heart is reduced by about 14% when the amount of vasopressin in the blood is not more than 20 milli-units per litre.
There is no direct evidence yet available. However, Burn and Singh Grewal (1951) have recovered 95 milli-units vasopressin from the urine of one subject who smoked two cigarettes, and they also showed that when vasopressin is injected intravenously, about 5% appears in the urine. From this they calculated that their subject who smoked 2 cigarettes had 1,900 milli-units in his blood, which may be reckoned as 380 milli-units per litre. This concentration would certainly cause a severe reduction in the coronary flow. However, this subject was unusually sensitive to nicotine, and it is unlikely that smoking would normally produce such high concentrations of vasopressm in the blood as this.
The electrocardiogram.-ECG changes have been recorded after smoking. Graybiel et al. (1938) found that 20 out of 45 subjects showed a lowering of the T wave, and sometimes an inversion of it. As a result of our studies on atrial fibrillation in Oxford we are coming to the conclusion that this depression of the T wave may indicate a diminution of the active transport of potassium from the plasma into the cardiac muscle, and as the active transport is carried out by metabolic processes which require oxygen, a depression of the T wave may indicate a diminution of the blood flowing through the coronary circulation. Roth et al. (1944) also observed a lowering of the T wave. Evans and Stewart (1943) also described a lowering of the T wave.
The ballistocardiogram.-Smoking has been observed to produce changes in the ballistocardiogram (Dock et al., 1951; Caccese and Schrager, 1951; Kelly et al., 1954) . The changes were rarely seen in young people, but were common in persons with coronary artery disease. This observation has been confirmed by Starr (1954) who considers that evidence of a change in the ballistocardiogram produced by smoking can be used as evidence of coronary disease.
Conclusion concerning the heart.-Thus the findings all point in the same direction that nicotine has an effect on the heart which, while harmless in the young and healthy person, is harmful in those who are older, and especially in those with coronary disease. This effect may be due to the release of vasopressin which reduces the coronary blood flow, or it may be due to the action of nicotine on chromaffin tissue in the heart causing the release of adrenaline and noradrenaline, which my colleague Kottegoda (1953b) has also demonstrated.
I would like to conclude with an expression of surprise that doctors seem often disinclined to tell their patients not to smoke. McDevitt and Wright (1955) 
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It was difficult to attribute the results of these two investigations to a tendency for doctors to diagnose lung cancer more readily among heavy cigarette smokers, since the association with smoking was stronger for histologically proven cases than for all cases. Neither could it be due to the effect, postulated by Berkson (1955) , of special selection of persons to be included in the study as a result of reticence on the part of heavy smokers to respond to questions about their smoking habits. Such an effect should wear off in the course of a few years, but in the British study the relationship with smoking had remained unaltered over four years, while in the American study it was becoming stronger with the passage of time. It could not be that smoking merely determined the site in which a predetermined cancer developed, since in this case there would need to be a lower mortality from forms of cancer other than lung cancer among heavy smokers-and this was not observed. The simplest explanation of the facts was that cigarette smoking was a major cause of lung cancer. It was impossible to exclude the possibility that the association might be indirect, but in so far as any such mechanism had been suggested which was capable of testing, this had been disproved. For example, the association did not arise because heavy smokers specifically tended to live in big towns where they were exposed to atmospheric pollution. In the British investigation the smoking habits of the doctors were much the same wherever they lived, whereas in the American investigation, which was on a larger scale, it had been possible to show that the relation with smoking held-and was in fact much the same-in all types of residential area. The suggestion that the fundamental factor might be alcohol consumption was disproved by the work of Wynder et al. (1956) who showed that there was no significant difference between the amounts of alcohol drunk by patients with and without lung cancer, if the amounts smoked were kept constant.
The conclusion that cigarette smoking was a major cause of lung cancer accorded well with many of the other observed facts about lung cancer. For example, a detailed pathological study of the bronchial mucosa of patients dying of various types of cancer had shown that hyperplasia and metaplasia of the basal cell layer and the presence of carcinomain-situ became progressively more common as the amount smoked increased and was commonest of all among patients who had died of lung cancer. The increase in the deathrate in this country had followed the increase in cigarette consumption by about twenty years; it had been more rapid than the increase in cigarette consumption but some of the increase in the death-rate must be attributed to improvements in diagnosis. It remained to be seen whether the lung cancer death-rate would become stable in the future, following the relative stabilization of cigarette consumption over the last decade. The difference in the recorded mortality in different countries correlated well with the annual consumption of cigarettes in those countries twenty years previously; the mortality in Britain was, however, somewhat higher and the mortality in the U.S.A. somewhat lower than would be expected from comparison with other countries. The ratio of the recorded death-rates among men and women accorded with what was known of the past smoking habits of the two sexes.
Medical Effects of Smoking
Clinical aspects.-Of the dozen or so alkaloids which have been isolated from the tobacco plant, nicotine has established itself as being the most important. The pharmacological properties of nicotine are now well understood, the main effect being upon the sympathetic nerves, which are first stimulated and later, if the dosage be sufficient, paralysed. It is a stimulant to the central nervous system, and in toxic doses may produce convulsions. As with other habit-forming drugs, experimental investigations have been hampered, both in man and animals, by the differences in response to large and small doses in those who have or have not been previously exposed.
The vaso-constrictor effect is seen clinically in peripheral vascular disease and angina pectoris. Whilst no one would claim that either of these diseases was caused by smoking, the symptoms are occasionally intensified by it, and at least a trial period of abstinence should be recommended. Thrombo-angiitis obliterans, if indeed such an entity exists, falls into a rather different category, as it seems to bear a direct relation to smoking, so that smoking should always be forbidden in this disease. group in both sexes. This is hardly surprising, but the close correlation between the prevalence of bronchitis and sex in each group of smokers and non-smokers is remarkable, strongly suggesting that, when age, domestic and working conditions are standardized, the different rates for bronchitis in men and women are related to smoking habits.
The tobacco habits of 1,000 bronchitics have been investigated at the Bronchitis Clinic, Brompton Hospital. All except 106 had smoked at some time, and they were asked their opinions of the effect of smoking upon their bronchitis. The results are set out in Table II . The majority agreed that their bronchitis was aggravated by smoking and a surprisingly high proportion of them had cut down or abandoned the habit with benefit. The precise relationship between smoking and bronchitis cannot be defined. The suggestion has been made that tobacco smoke acts as a chemical poison upon the bronchial epithelium; certainly, it promotes the excessive formation of mucus, and it seems to predispose to chronic bronchitis. Its effects are likely to be influenced to some extent by individual differences in response to bronchial irritation. The commonest effect is the expectoration of mucoid sputum, which diminishes rapidly on the cessation of smoking, at least in the early stages; later, the condition may become permanent, causing little disability. At any stage in this process, bronchospasm may supervene, in which case breathlessness becomes apparent, and the sooner smoking is abandoned the better; unfortunately, once clinical bronchospasm has become evident, it is extremely difficult to eradicate unless it does so fairly promptly on the withdrawal of tobacco.
The excessive formation of bronchial mucus from any cause, and one cause is undoubtedly tobacco smoking, inevitably leads to a predisposition towards bronchial infection, the so-called "resistance lowering effect" of mucus. To this extent, smoking hastens the onset of true chronic bronchitis, in which clinical evidence of an infective element exists, and this effect may well be enhanced by any poisonous action that tobacco smoke may have upon the bronchial epithelium.
